Clinical Trial Update: Trial Combining Pembrolizumab and Cesium 131 Brachytherapy With Salvage Surgery in HNSCC [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/Phase 2 trial evaluating pembrolizumab with Cesium-131 brachytherapy followed by salvage surgery for head and neck squamous cell carcinoma; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: University of Cincinnati | Conditions: HNSCC | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING